7 Company A is a pharmaceutical start-up founded 18 months ago. The company is developing its first product (a new synthetic protein) that will be available at beginning of 2023. So far, the company had no revenues and got significant funds from banks to purchase the laboratory equipment and the machinery needed for running the R&D activities. What multiple should be preferred to evaluate Company A? (banjos: 2) Relative valuation should be assets-based, and the most correct multiple would be EV / Sales. Relative valuation should be assets-based, and the most correct multiple would be EV / EBITDA. Relative valuation should be equity-based, and the most correct multiple would be Price-to-Earnings (P/E). None of the other answers. - nich of the following is an example of a productivity indicator for a manufacturing company? : 2) Michela Arnaboldi